+Compare
NEOG
Stock ticker: NASDAQ
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
3.63B

NEOG Price Prediction, Neogen Corp AI Recommendations

Stock market charts, price targets, analyst ratings and a financial calendar

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for NEOG with price predictions
07:00 PM EST Nov 30, 2023

NEOG in upward trend: 10-day moving average broke above 50-day moving average on November 29, 2023

The 10-day moving average for NEOG crossed bullishly above the 50-day moving average on November 29, 2023. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 14, 2023. You may want to consider a long position or call options on NEOG as a result. In of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

NEOG moved above its 50-day moving average on November 22, 2023 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NEOG advanced for three days, in of 295 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 228 cases where NEOG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 10 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The 50-day moving average for NEOG moved below the 200-day moving average on October 25, 2023. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NEOG declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

NEOG broke above its upper Bollinger Band on November 03, 2023. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NEOG’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.154) is normal, around the industry mean (25.181). P/E Ratio (47.393) is within average values for comparable stocks, (79.550). Projected Growth (PEG Ratio) (0.658) is also within normal values, averaging (6.249). Dividend Yield (0.000) settles around the average of (0.019) among similar stocks. P/S Ratio (3.946) is also within normal values, averaging (44.232).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NEOG’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

A.I. Advisor
published Earnings

NEOG is expected to report earnings to fall 48.45% to 5 cents per share on January 04

Neogen Corp NEOG Stock Earnings Reports
Q4'23
Est.
$0.06
Q3'23
Beat
by $0.06
Q2'23
Beat
by $0.13
Q1'23
Beat
by $0.09
Q4'22
Beat
by $0.23
The last earnings report on October 10 showed earnings per share of 10 cents, beating the estimate of 5 cents. With 1.23M shares outstanding, the current market capitalization sits at 3.63B.
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Intuitive Surgical (NASDAQ:ISRG), Medtronic plc (NYSE:MDT), Boston Scientific Corp (NYSE:BSX), Edwards Lifesciences Corp (NYSE:EW), IQVIA Holdings (NYSE:IQV), Align Technology (NASDAQ:ALGN), Illumina (NASDAQ:ILMN), Exact Sciences Corp (NASDAQ:EXAS), Guardant Health (NASDAQ:GH).

Industry description

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

Market Cap

The average market capitalization across the Medical Specialties Industry is 6.4B. The market cap for tickers in the group ranges from 27 to 3.82T. MKYSF holds the highest valuation in this group at 3.82T. The lowest valued company is FOGCF at 27.

High and low price notable news

The average weekly price growth across all stocks in the Medical Specialties Industry was 4%. For the same Industry, the average monthly price growth was 13%, and the average quarterly price growth was 704%. LNDZF experienced the highest price growth at 347%, while SDCCQ experienced the biggest fall at -31%.

Volume

The average weekly volume growth across all stocks in the Medical Specialties Industry was 107%. For the same stocks of the Industry, the average monthly volume growth was -5% and the average quarterly volume growth was 13%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 69
Price Growth Rating: 60
SMR Rating: 84
Profit Risk Rating: 88
Seasonality Score: 17 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a maker of medical testing kits

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
620 Lesher Place
Phone
+1 517 372-9200
Employees
2640
Web
https://www.neogen.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
EDD4.790.12
+2.57%
Morgan Stanley Emerging Markets Domestic Debt Fund
EDOG21.140.28
+1.36%
ALPS Emerging Sector Dividend Dogs ETF
BMAY32.910.15
+0.46%
Innovator U.S. Equity Buffer ETF™- May
IBDO25.290.01
+0.04%
iShares iBonds Dec 2023 Term Corp ETF
KEJI10.88N/A
N/A
Global X China Innovation ETF

NEOG and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEOG has been loosely correlated with RVTY. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if NEOG jumps, then RVTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEOG
1D Price
Change %
NEOG100%
+2.77%
RVTY - NEOG
50%
Loosely correlated
+2.68%
COO - NEOG
43%
Loosely correlated
+1.24%
IQV - NEOG
43%
Loosely correlated
+1.31%
KIDS - NEOG
42%
Loosely correlated
+1.49%
PACB - NEOG
41%
Loosely correlated
+4.72%
More